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Two different isoforms of subunit VIIa have been found in cytochrome c oxidase isolated from human skeletal muscle. The first 22 residues of 
the N-terminal amino acid sequences showed 5 differences. Our results provide the first conclusive evidence for the existence of cytochrome c oxidase 
isoenzymes in man. Since the two cytochrome c oxidase isoforms were both present in skeletal muscle tissue, though not necessarily in the same 
cell type, this suggests that human cytochrome c oxidase isoforms are not strictly tissue-specific. These findings may have important implications 
for the elucidation of genetic diseases in man in which a deficiency of cytochrome c oxidase is restricted to certain tissues. 
Human cytochrome c oxidase isoenzyme; Mitochondrial myopathy 
1. INTRODUCTION 
Cytochrome c oxidase, the terminal enzyme of the 
respiratory chain, catalyzes the oxidation of fer- 
rocytochrome c by molecular oxygen. The three largest 
subunits (I-III) of the mammalian enzyme are encoded 
by the mitochondrial genome [l], while the 10 smaller 
subunits are encoded by nuclear genes. Tissue-specific 
immunological and electrophoretic differences in these 
nuclearly coded subunits have been demonstrated in 
cytochrome c oxidase purified from several tissues of 
the same mammalian species [2,3]. The discovery of 
isoenzyme forms of bovine cytochrome c oxidase was 
confirmed by N-terminal amino acid sequence data, 
which revealed that different ‘heart-type’ and ‘liver- 
type’ isoforms of the subunits Via, VIIa and VIII were 
present in cytochrome c oxidase purified from bovine 
heart and liver tissue, respectively [3]. In view of subse- 
quent findings with cytochrome c oxidase from other 
mammalian species [4,5], we prefer to expand the 
definition of ‘bovine heart-type’ and ‘bovine liver-type’ 
isoforms to other species. 
However, the situation in man with regard to 
cytochrome c oxidase was not clear. It is now well- 
established that in patients with mitochondrial diseases 
a mitochondrial enzyme may be deficient in some 
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tissues but not in others (see [6-91 for reviews). This is 
often the case in patients with a deficiency of 
cytochrome c oxidase [8-151. For instance, in one type 
of fatal infantile myopathy there is a deficiency of 
functional cytochrome c oxidase in skeletal muscle, 
while normal levels of the active enzyme are observed 
in other tissues. The existence of oxidase isoforms 
would provide an explanation for these observations. 
Recently we determined the amino acid sequence of 
subunit VIII isolated from human heart cytochrome c 
oxidase, which proved to be a ‘bovine liver-type’ [4]. 
However, a ‘bovine heart-type’ subunit VIII has not yet 
been found in man. Furthermore, only ‘bovine liver- 
type’ cDNAs specifying the subunits Via, VIIa and 
VIII of human cytochrome c oxidase have been 
published [16-181. These findings led to doubt about 
the existence of tissue-specific isoenzymes of human 
cytochrome c oxidase. Our study proves the existence 
of human cytochrome c oxidase isoforms through the 
identification of two different isoforms of subunit VIIa 
in a single preparation of human muscle cytochrome c 
oxidase. 
2. MATERIALS AND METHODS 
2.1. Purification of cytochrome c oxidase and fractionation of the 
small subunits 
Human skeletal muscle (quadriceps) was obtained at abduction. 
Cytochrome c oxidase was purified according to the same procedure 
as described before for human heart cytochrome c oxidase [4], essen- 
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tially by differential extraction of submitochondrial particles with 
deoxycholate. 
The nuclearly encoded subunits were separated from the mitochon- 
drially encoded subunits using the method of Power et al. [19] with 
the following modifications: after preparing supernatant Sl, the final 
pellet (Pl) was resuspended in 1.25% triethylamine (TEA) and 1.25% 
trifluoroacetic acid (TFA). One volume of the mixed solvent 
acetonitrile/l-propanol (1 : 1, 0.05% TEA, 0.05% TFA) was added 
to the suspension and the mixture was stirred for 3 h on ice. After 
centrifugation, the supernatant was retained and the pellet extracted 
once more. The third extraction was carried out overnight and after 
centrifugation, the final extraction was carried out for 3 h. All four 
supernatants were pooled and designated supernatant S2. Both super- 
natants Sl and S2 and the final pellet P2 were lyophilized and saved 
for further analysis. 
2.2. Purification of subunits VIIa (1) and VIIa (2) with reversed- 
phase HPLC 
Subunits Vlla (1) and Vlla (2) (for a definition see section 3) were 
purified from supernatant S2. Aliquots of supernatant were dissolved 
in 8 M guanidine HCl/O.OS% TFA and incubated for 1 h at room 
temperature. Dithiothreitol (10 mM) was added 15 min prior to in- 
jection into the HPLC system. HPLC was performed on a Brownlee 
(Santa Clara, CA) column (type RP-300, Aquapore octyl, 300 A size, 
7 gm spherical, 220 x 4.6 mm) and a guard column (type RP-8 
Aquapore ODS, 7 pm spherical). The HPLC system consisted of two 
LKB 2150 pumps, a 2152 LC controller, a Rheodyne 7125 injector 
and an LKB Uvicord 2138 S detector operating at 280 nm. The 
solvents used for chromatography consisted of 0.05% TFA/O.OS% 
TEA/S% acetonitrile/water (solvent A) and 0.05% TFA/O.OS% 
TEA/50% acetonitrile/50% 1-propanol (solvent B). 
2.3. Polyacrylamide gel electrophoresis 
Tricine-SDS gel electrophoresis was performed according to Schag- 
ger and Von Jagow [20]. Gels (30 x 18 x 0.15 cm) were prepared with 
glycerol instead of urea. The samples were incubated in sample buffer 
and ,/_?-mercaptoethanol was added up to 2% (v/v) 1 h prior to the 
start of the gel electrophoresis run. Gels were stained overnight with 
Coomassie brilliant blue. 
2.4. Determination of the N-terminal amino acid sequences of 
subunits VIIa (I) and VIIa (2) 
The determination of the N-terminal sequence was carried out on 
a 477A pulsed-liquid sequencer (Applied Biosystems, USA) with on- 
line analysis of the phenyl thiohydantoin amino acids on a 120A PTH 
analyzer (Applied Biosystems). 
3. RESULTS 
From supernatant S2 we could purify two different 
subunits VIIa of human muscle cytochrome c oxidase 
which had different retention times on a reversed-phase 
column. Part of the elution profile of S2 is shown in 
Fig. 1. The two different subunits VIIa, designated by 
us as VIIa (1) and VIIa (2), eluted around 41% solvent 
B. Fig. 2 shows the analyses by gel electrophoresis of 
the two human muscle subunits VIIa, purified with 
reversed-phase HPLC. The two distinct bands in the 
subunit VII region of subunit VIIa (2) are probably due 
to different conformations of the protein, since 
subunits VIIb and VIIc have a free N-terminus (un- 
published results) and analysis of the N-terminal amino 
acid sequence of both subunits VIIa revealed no signifi- 
cant contamination with other proteins. The additional 
minor bands of higher molecular mass are probably 
dimeric forms of the subunits VIIa (1) and VIIa (2). 
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Fig. 1. Part of the HPLC-elution profile of supernatant S2 (for 
details see section 2). The 280 nm absorbance is given by the solid 
line, the dashed line represents the percentage of solvent B in the 
gradient. 
This phenomenon was also observed for several other 
purified subunits (unpublished results). 
In Table I the N-terminal amino acid sequences of 
subunits VIIa (1) and VIIa (2) from human muscle are 
presented together with the complete amino acid se- 
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Fig. 2. The analysis by gel electrophoresis of SO pmol of the human 
muscle cytochrome c oxidase subunits VIIa (1) and VIIa (2) 
(described under section 3), purified with reversed-phase HPLC. 
Purified human muscle cytochrome c oxidase (120 pmol) was used as 
a reference. The gel was stained with Coomassie blue. 
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The N-terminal amino acid sequences of the subunits Vlla (1) and Vlla (2) (see section 3) of human skeletal muscle cytochrome c oxidase 
as determined by us and comparison with the complete amino acid sequences of subunit Vlla of bovine heart [21], bovine liver subunit 
VIla [22], and human endothelial cell subunit Vlla [I61 
Bovine heart 
Human muscle (1) 
Human muscle (2) 
Human endotheljal 
Bovine liver 
Bovine heart. 
Human muscle (1) 
Human muscle (2) 
Human endothelial 
Bovine liver 
Bovine heart 
Human muscle (1) 
Human muscle (2) 
Human endothelial 
Bovine liver 
Bovine heart 
Human muscle (1) 
Human muscle (2) 
Human endothol i al 
Bovine liver 
Phc Lvs-Asn Lvs Val-Pro Glu Lvs-Gin-Lvs-Leu-Phe Gin-Glu-Aso 
Phe Giu-As" L;s~Val~Pro~Glu~L;s~Gln L;s Leu Phe-Gin-Glu-As;- 
16 20 25 30 
As" Gly Leu Pro~Val His Leu Lys Gly-Gly Ala-Thr~Asp-Asn lie- 
IAsn AsptIle Pro Leu Tyr-Leu-Lys-Gly-Gly Ile Val-Asp As"-11~ 
[Asp GlutlIe Pro~Leu-Tyr I,eu~ .__..._..__..___.._..._..__.._ 
Asp~Glu 110 Pro Leu-Tyr I.ewLys Gly~Gly~Val~Ala~Asp~Ala~Leu~ 
Asn Gly lie Pro Val His~Leu~I,ys~Gly~Gly~Ile~AlaAspAlaArg 
31 35 40 45 
Leu Tyr Arg Val~Thr-Met Thr Leu Cys Leu Gly Gly Thr-Leu-Tyr 
Leu Tyr Arq Val Thr Met~Thr-Leu ..__.___..__.._..._..__..__ 
. . . . . . . . . . . . . . . . . . . . . . . . . .._..._..._..__..__..__..__.._..._ 
Leu Tyr Arg Ala Thr Met Ile~Leu Thr-Val-Gly-Gly-Thr-Ala-Tyr- 
Leu Tyr-Arq~Ala-ThrLeu Ile Leu Thr-Val-Gly-Gly-Thr-Ala-Tyr- 
46 50 55 60 
Sor Leu Tyr Cys Leu~Gly~His~Ala~Ser~Lys~Lys 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Ala Ile Tvr Glu~Geu-Ala Val~Ala Ser~Phe~Pro~LVs~Lvs~Gln~Glu 
Ala Met T;r-Glu Leu~Ala-Val-Ala~Ser Phe~Pr"~L;s~L;s~Gln~Asp 
The sequences given for bovine liver and human endothelial cell subunit Vlla were derived from the cDNA sequence. Part of the sequences 
of the human muscle subunits Vlla (1) and Vlla (2) that have not yet been determined are indicated by dotted lines. Differences in sequence 
of subunit Vlla (1) and subunit Vlla (2) of human muscle cytochrome c oxidase have been boxed 
quence of bovine heart [21], bovine liver [22] and 
human endothelial subunit VIIa [16]. The sequences 
given for bovine liver and human endothelial subunit 
VIIa were derived from the cDNA sequence. Amino 
acid sequence analysis allowed unambiguous identifica- 
tion of 38 and 22 residues, respectively, of the N- 
terminal amino acid sequences of subunits VIIa (1) and 
VIIa (2). The first 22 residues of the N-terminal amino 
acid sequence of subunits VIIa (1) and VIIa (2) found 
in human muscle cytochrome c oxidase showed 5 dif- 
ferences. Of the first 38 residues of the human skeletal 
muscle subunit VIIa (l), 30 residues proved to be iden- 
tical to those of bovine heart, and 26 identical to those 
of bovine liver. On the other hand, of the first 22 
residues of subunit VIIa (2), 14 residues were identical 
to those of bovine heart and 17 identical to those of 
bovine liver. Thus, the N-terminal sequence of the 
human muscle subunit VIIa (1) is more closely related 
to that of bovine heart than to its bovine liver counter- 
part, while that of the human muscle subunit VIIa (2) 
is more closely related to the sequence of bovine liver. 
This indicates that both a ‘bovine heart-type’ subunit 
VIIa (1) and a ‘bovine liver-type’ subunit VIIa (2) are 
present in human skeletal muscle. 
Furthermore, the N-terminal sequence of the ‘bovine 
liver-type’ subunit VIIa (2) proved to be completely 
identical to the amino acid sequence deduced from the 
base sequence of a cDNA specifying subunit VIIa of 
human endothelial cells [ 161. An important observation 
is that the concentration of the ‘bovine liver-type’ 
subunit VIIa (2) in our human skeletal muscle oxidase 
preparation was only about 10% of that of the ‘bovine 
heart-type’ subunit VIIa (l), as judged from the se- 
quence yields. 
4. DISCUSSION 
Our results provide the first direct evidence at the 
level of gene-products for the occurrence of isoforms of 
human cytochrome c oxidase. It is as yet not clear 
whether these two isoforms occur in all skeletal muscle 
cells or fibers, or are restricted to certain cells or fibers. 
Since only a minor amount of subunit VIIa (2) was pre- 
sent, it cannot even be excluded that this ‘bovine liver- 
type’ subunit was derived from endothelial cells lining 
the blood vessels in skeletal muscle. Nonetheless, our 
results may have several implications in view of the 
molecular background related to the occurrence of 
mitochondrial myopathies in man. First, a mutation in 
a nuclear gene encoding an isoform of a subunit of 
cytochrome c oxidase expressed in skeletal muscle but 
not in other tissues or organs such as heart could pro- 
vide a ready explanation for a tissue-specific deficiency 
of the enzyme. Of course, this need not always be the 
case: in many patients defects in the respiratory chain 
are accompanied by deletions in mitochondrial DNA 
[23-261 and the variability in the expression of the defi- 
ciency in different tissues has been attributed to 
heteroplasmy [24]. 
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Second, since we have now shown that two isoforms 
of cytochrome c oxidase occur in skeletal muscle, this 
could provide an explanation for the fact that in certain 
mitochondrial myopathies there is only a partial defi- 
ciency of cytochrome c oxidase. 
Third, there are several case reports of infants with 
a reversible form of infantile mitochondrial myopathy 
with cytochrome c oxidase deficiency [27-291. A muta- 
tion affecting a fetal or neonatal isoenzyme form of a 
subunit of cytochrome c oxidase, but not the adult 
isoform, could explain the transient expression of 
cytochrome c oxidase deficiency in the neonatal period 
PI. 
Our results offer also for the first time evidence at 
the protein level for the occurrence of two isoforms of 
a subunit of cytochrome c oxidase purified from one 
tissue. At the cDNA level two isoforms of subunit Via 
have been identified in a rat-heart cDNA library [5]. 
Our findings might also imply that the human oxidase 
does not show the type of tissue specificity that has 
been reported for the oxidase in other mammals [3]. 
For instance, in bovine cytochrome c oxidase no 
evidence has been presented up to now for the occur- 
rence of two different isoforms of subunit VIIa in one 
tissue. However, it cannot yet be excluded that bovine 
heart cytochrome c oxidase contains an additional 
minor amount of a ‘bovine liver-type’ subunit VIIa 
besides the published ‘bovine heart-type’ subunit VIIa. 
In that study [21], subunit VIIa of bovine heart 
cytochrome c oxidase was purified by gel filtration and 
the presence of a small amount of a second type VIIa 
polypeptide might well have been overlooked. 
Reasoning along these lines, it will be most relevant 
to see whether cytochrome c oxidase purified from 
human heart also contains two different isoforms of 
subunit VIIa. Investigation of the amino acid sequences 
of several subunits of cytochrome c oxidase from 
human heart and skeletal muscle is in progress in our 
laboratories. This will yield more information about 
the tissue specificity of the human cytochrome c ox- 
idase isoenzymes, and about the function of the dif- 
ferent isoenzymes [30]. 
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